BioVectra Announces Vaccine Manufacturing Facility

Charlottetown-based BioVectra, which manufactures pharmaceutical ingredients, has announced it will build one of Canada’s first mRNA vaccine manufacturing facilities in a project worth $76.9 million.
The federal government will pay $39.8 million of the total cost and the P.E.I. government $10 million, with the balance born by BioVectra.
The drugmaker was bought by private equity firm H.I.G.